College of Pharmaceutical Science, Zhejiang Chinese Medical University, No. 548, Binwen Road, Binjiang District, Hangzhou, Zhejiang, 310053, China.
Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, No. 18, Chaowang Road, Xiacheng District, Hangzhou, Zhejiang, 310014, China.
BMC Complement Med Ther. 2024 Aug 23;24(1):315. doi: 10.1186/s12906-024-04583-2.
Metabolic syndrome (MetS) is a precursor to the development of many diseases (atherosclerosis, diabetes, etc.). It is marked by disruptions in glucose and lipid metabolism, along with hypertension. Numerous types of risk factors contribute to the development of the MetS, inflammation and insulin resistance are present throughout the metabolic abnormalities. Chrysanthemum indicum L. is a traditional Chinese plant used for both tea and medicine, known for its high content of total flavonoids, which are important secondary metabolites. Our research led to the extraction of a Buddleoside-Rich Chrysanthemum indicum L. extract (BUDE) which has demonstrated anti-inflammatory properties. Nonetheless, the specific role and mechanism of BUDE in preventing MetS remain unclear.
The study initially evaluated the role of BUDE in preventing MetS. Subsequently, it investigated the anti-inflammatory properties of BUDE in the liver and pancreas in response to unhealthy diets. It then examined the level of insulin resistance and pancreatic β-cell function induced by inflammation. Additionally, an lipopolysaccharide (LPS)-induced macrophage inflammation model was used to further investigate the ameliorative effects of BUDE in inflammation.
BUDE has hypotensive, hypoglycemic and hypolipidemic effects. It can also resolve the imbalance between macrophage subpopulations, impede the triggering of the NF-κB signaling pathway, reduce the secretion of inflammatory mediators, ameliorate insulin resistance, and safeguard organs such as the liver and pancreas from inflammatory damage. These effects collectively contribute to preventing the development of MetS.
BUDE has the ability to modulate macrophage-mediated inflammation, leading to improved insulin resistance. Additionally, it delivers antihypertensive, hypoglycemic, and hypolipidemic effects, offering a potential for preventing MetS.
代谢综合征(MetS)是许多疾病(动脉粥样硬化、糖尿病等)发展的前兆。其特征是葡萄糖和脂质代谢紊乱,同时伴有高血压。许多类型的危险因素导致 MetS 的发生,炎症和胰岛素抵抗存在于代谢异常的各个环节。菊花是一种传统的中国植物,既用于茶饮也用于医药,以其高含量的总黄酮而闻名,总黄酮是重要的次生代谢产物。我们的研究导致提取出一种富含马钱苷的菊花提取物(BUDE),具有抗炎特性。然而,BUDE 预防 MetS 的具体作用和机制尚不清楚。
本研究首先评估了 BUDE 在预防 MetS 中的作用。随后,研究了 BUDE 在不健康饮食下对肝脏和胰腺的抗炎作用。接着,研究了炎症引起的胰岛素抵抗和胰腺β细胞功能的水平。此外,还使用脂多糖(LPS)诱导的巨噬细胞炎症模型进一步研究了 BUDE 在炎症中的改善作用。
BUDE 具有降压、降糖和降脂作用。它还可以解决巨噬细胞亚群的失衡,阻止 NF-κB 信号通路的触发,减少炎症介质的分泌,改善胰岛素抵抗,并保护肝脏和胰腺等器官免受炎症损伤。这些作用共同有助于预防 MetS 的发生。
BUDE 能够调节巨噬细胞介导的炎症,从而改善胰岛素抵抗。此外,它还具有降压、降糖和降脂作用,为预防 MetS 提供了一种潜在的方法。